A major new advancement in skincare has been unveiled at this year’s American Academy of Dermatology meeting. The meeting is still underway, but the new technology, called CYTOMIMIC Technology from Johnson & Johnson Consumer Companies, Inc. is already proving to be among the biggest news to come out of the AAD meeting.

Building on decades of research into how the body’s electrical field affects skin regeneration, scientists at Johnson & Johnson Consumer Companies, Inc., have discovered how to harness the power of bioelectricity to help improve skin rejuvenation.

CYTOMIMIC Technology: How It Works

Bioelectricity is the body’s native electrical signaling process that helps direct physiological activities at the cellular level, such as the skin’s own rejuvenation process. When applied topically, CYTOMIMIC Technology can help to rejuvenate and maintain healthy-looking skin.

As we age, bioelectrical signals naturally diminish which can result in decreased cell-to-cell communication, production of essential proteins such as collagen and elastin, and in healing abilities. This can result in fine lines and wrinkles, loss of firmness and sagging skin.

The science of CYTOMIMIC Technology is based on creating and delivering biological levels of electricity directly to the skin, naturally stimulating the intrinsic rejuvenation process. This innovation is based on the design of a proprietary technology – energized micro-particles of zinc and copper – captured in a unique delivery system that helps stimulate the body’s own rejuvenation processes. When activated by moisture, these energized micro-particles act as “miniaturized batteries” that help jumpstart healthy skin function. These micro-particles stay on the skin’s surface and mimic the body’s native electrical signals, to rebuild and restore youthful-looking skin.

Interpretations of the CYTOMIMIC Technology are now incorporated into products from favorite mass skincare brands Neutrogena, AVEENO, and RoC.

Neutrogena Clinical Skin Care